Our Leadership

John Chiminski was named President and Chief Executive Officer of Catalent Pharma Solutions in March 2009. Mr. Chiminski has a diversified business background that spans operations, research and development, services, and global leadership.

He joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations and senior leadership roles.  From 2007 until he left in 2009, Mr. Chiminski served as President and Chief Executive Officer of GE Medical Diagnostics, a diagnostic pharmaceutical business with sales of $1.9 billion.  From 2005 to 2007, he served as Vice President and General Manager of GE Healthcare’s Global Magnetic Resonance Business, and from 2001 to 2005, Mr. Chiminski served as Vice President and General Manager of Global Healthcare Services. Earlier in his time at GE, Mr. Chiminski held a series of cross-functional leadership positions in both manufacturing and R&D, including a GE Medical Systems assignment in France.  

Mr. Chiminski holds a B.S. from Michigan State University and an M.S. from Purdue University, both in electrical engineering, as well as a Master in Management degree from the Kellogg School of Management at Northwestern University. 

He is on the Board of Trustees for HealthCare Institute of New Jersey.

Lance Miyamoto was named Senior Vice President of Human Resources of Catalent in March 2011. Mr. Miyamoto has more than 25 years experience in delivering HR systems including compensation and career structures that drive business results and growth.  In addition to general HR expertise and organization development, he has experience leading in a global environment and has managed global company turnarounds, mergers and acquisitions.

Prior to his own consulting business, Mr. Miyamoto held a number of HR leadership roles in other companies, including Executive Vice President of Comverse Technology Inc. He also served as Executive Vice President of HR for AOL LLC, a division of Time Warner, from 2004 to 2007.

From 2001 to 2004, Mr. Miyamoto was Executive Vice President of HR for Lexis-Nexis, a $2.2 billion division of Reed Elsevier. He was also a senior executive with Dun and Bradstreet with responsibility for performance development.  Early in his career, Mr. Miyamoto was an HR specialist at Avon Products and at Exxon, working closely with leaders and employees in R&D, manufacturing, sales, and services.

Mr. Miyamoto is a graduate of Harvard University, and holds an M.B.A. from the Wharton School of the University of Pennsylvania where he was a COGME (Council for Graduate Management Education) Fellow.


Ian Muir, PhD was named President of Modified Release Technologies of Catalent in June 2010.  Dr. Muir is a registered pharmacist in the United Kingdom. After working for a short period in hospital pharmacy and for GlaxoSmithKline, he returned to academia to complete a doctorate at Nottingham University. His research focused on the biological distribution and retention of biodegradable microspheres in the systemic circulation.

Dr. Muir joined Catalent when it was operating as RP Scherer in 2000 as head of project management in the UK. Subsequently, he served as the Director of Oral Product Development and as business leader for the Zydis^® fast dissolve technology segment. In 2005, he was promoted to Vice President of Technical Operations and then named Vice President and General Manager of Modified Release Technologies in 2007.

Prior to Catalent, Dr. Muir also held roles within product development, technical operations, and program management at Bristol-Meyers Squibb, Wyeth, and Faulding/DBL Pharmaceuticals in the US, UK, and Australia.

Scott Houlton was named President of Development and Clinical Services of Catalent in August 2009. Mr. Houlton has an extensive background in leading global organizations, with particular expertise in the area of development services, including preclinical, formulation, analytical testing, manufacturing, packaging, and international logistics services.

Mr. Houlton joined Catalent after serving as Chief Operating Officer at Aptuit, Inc., where he led global teams that provided developmental services to customers. His responsibilities also included strategic planning and integrations related to new acquisitions. Before that, he held the position of President of Clinical Operations at Aptuit.

Prior to Aptuit, Mr. Houlton held a variety of leadership roles in other companies, including Vice President of Clinical Supplies at Quintiles Transnational Corporation. Earlier in his career, he was with Cardinal Health, where he served as Director of International Business Development.

Mr. Houlton holds a BS in both international business and finance from The Ohio State University.

Kurt Nielsen was named Chief Technology Officer and Senior Vice President of Innovation and Growth of Catalent in February 2010. Dr. Nielsen is responsible for driving innovation activities and investments across Catalent’s broad range of advanced dose forms and packaging technologies. He has an extensive background in both pharmaceutical sciences and commercial activities.

His expertise in scientific strategy development, as well as oversight of clinical development, medical affairs, and research and development areas, combines scientific and business acumen in the service of Catalent’s customers.

Dr. Nielsen joined Catalent after serving as Executive Vice President of Pharmaceuticals at URL Mutual Pharmaceutical Company. In that role, he devised the strategy and launch of the company’s new product portfolio as well as completed multiple deals ranging from licensing to partnerships to joint ventures.

Before that role, he was Vice President of R&D, where he established global supply chain and development relationships with companies in Europe, India, and China.

Prior to URL Mutual, Dr. Nielsen held a variety of executive positions with TEVA Pharmaceuticals USA; McNeil Consumer Products; Energy Biosystems, Inc.; Bachem Bioscience; Hercules, Inc.; Arco Chemical Company; and Chubb National Foam.

Dr. Nielsen’s PhD is in chemistry from Villanova University; he also holds a BS in chemistry from the University of Delaware.

Sharon Johnson was named Senior Vice President of Global Quality and Regulatory Affairs of Catalent in August 2009. Ms. Johnson is a quality professional with more than 25 years of experience in the pharmaceutical industry, predominantly in the area of sterile products and biosciences.

Ms. Johnson joined Catalent after six years at GE Healthcare, where she was Vice President of Quality for GE Healthcare, Medical Diagnostics, in Buckinghamshire, England.

Prior to GE, she was Quality Director for Baxter Healthcare’s Europe operations for four years. Before that, she was with Rhone Poulenc Rorer as Quality Manager for Sterile Products and Microbiology in Essex, England. Earlier in her career, Ms. Johnson held Quality and Microbiology positions with Berk Pharmaceuticals in East Sussex, England, and Medicines Testing Laboratory in Edinburgh, Scotland.

Ms. Johnson holds a Post Graduate Diploma with Distinction in industrial pharmaceutical studies from Brighton University and holds a BS Honors Degree in biological sciences/microbiology from North East Surrey College of Technology.

Roy Satchell had served as Senior Vice President of Information Technology and Chief Information Officer of Catalent since April 2007. In December 2012, he was named Senior Vice President of Business Transformation. Mr. Satchell has more than 25 years of experience within the pharmaceutical and nutritional markets as well as several years of experience in the retail industry.

Mr. Satchell joined Catalent in 1997 at the Swindon, United Kingdom site. Over the years he has held a variety of leadership positions in IT and Operations, both in the U.K. and the U.S., including Senior Vice President of Information Technology for Cardinal Health and Vice President of Global Applications for Cardinal Health’s Pharmaceutical Technologies and Services business unit.

He previously worked at R. P. Scherer Corporation from 1982 to 1994, during which time the company was acquired by Cardinal Health. In 1994 he began working for Marley Extrusions, heading Logistics Projects, and then Supply Chain in the fast-moving consumer goods market; he rejoined Cardinal Health in 1997.

Mr. Satchell has a post-graduate degree in management studies and administrative management, both from Regents College, Swindon, U.K., and an MBA from Bristol University in Bristol, UK.

Charles Silvey was named Vice President of Internal Audit in April 2008 and has over 21 years experience in financial auditing and compliance. Before arriving at Catalent in 2008, he was the Practice Director for Internal Audit and Controls for Jefferson Wells International. He also served as Vice President of Internal Audit at Cambrex Corporation and Vice President of Financial and Operational Auditing for Automatic Data Processing, Inc.   Prior to that, he was the CFO of the Americas Services for Lucent Technologies, and in his early career worked as a finance manager for CR Bard, Inc. and KPMG Peat Marwick, LLP. 

Mr. Silvey has a bachelor’s degree in business from Monmouth University in West Long Branch, New Jersey. He is a certified public accountant and a member of the New Jersey Society of CPAs. Mr. Silvey also serves as a current panelist and featured speaker for the Center for Professional Education.